baber/WOPTO huggingface dataset:
Patent NZ-332770-A (NZ)
Title: Spraying apparatus comprises frames with spray ejectors for preserving produce
Inventor: KRAVITZ HOWARD S
IPC: A23B7/158
Filed: 1998-11-12
Abstract: An apparatus for administering treatments to prepacked boxes of produce comprises first  and second injector frames 20, 22 movably mounted to a main frame 10 and spray injectors 16, 17 adjustably mounted on injector frames 20, 22.  Spray injectors 16, 17 are positioned in alignment with each hand hole 18 exposed on each of two opposing sides of the vertically stacked boxes 14.  Means 23, 25, 34 is to move injector frames 20, 22 and there is means to alternate the pumping treatment solutions from a holding tank to the spray injectors mounted to first injector frame 20 and second to spray injectors mounted to second injector frame 22.
Patent NZ-333427-A (NZ)
Title: Wheelchair with inverted L shaped lateral members and front wheel supports connected to lateral members
Inventor: KUESCHALL RAINER
IPC: A61G5/08
Filed: 1998-12-17
Abstract: Wheelchair 10 has closed frame 12 formed by front horizontal transverse support 12.1 at foot height, two lateral supports 12.2/12.3 each in the form of an inverted "L" shape and rear transverse support (which constitutes an axle tube for a pair of rear wheels).  Front wheel supports 25 are fixed to respective upright legs of supports 12.2/12.3.
Patent NZ-335597-A (NZ)
Title: A method and flow system for spectrometry and a cuvette for the flow system
Inventor: FRANDSEN ANDREAS SKAERLUND
IPC: G01N21/359
Filed: 1997-10-31
Abstract: The application relates to an on-line method and a flow system as well as a cuvette for carrying out IR spectrometry for analysis of liquid food products, possibly containing dissolved gases, in a process line in a liquid food product processing plant, especially a dairy processing milk and milk products.  A liquid sample is extracted from the process line to a measuring branch, the sample is thermostated and passed to a measurement cuvette.  The IR-absorbance spectrum is measured, e.g. in the MID-IR or NIR-range. In order to obtain an on-line monitoring of the process line the liquid food sample is extracted directly from the process line into the measurement branch, in which the pressure is maintained at least as high as in the adjacent process line.  The high pressure ensures that dissolved air will stay dissolved in the liquid food.  Before each new sample the measurement branch and cuvette are flushed by high flow rates with a part of the new sample to clean the cuvette.  The measurement cuvette has strong windows, preferably diamond windows to stand a high pressure and high flow rates. The on-line system is arranged to carry out 120 measurements per hour.
Patent NZ-335943-A (NZ)
Title: Plant protection agents comprising 20[alpha-{[(alpha-methyl-3-trifluoromethyl-benzyl0imino]-oxy}-o-tolyl]gly oxylic acid-methylester-o-methyloxime and another component.
Inventor: MARGOT PAUL
IPC: A01N37/24
Filed: 1997-12-11
Abstract: These microbicide composition for plants, contains at least two active ingredient components in an amount producing synergistic activity, together with an appropriate filler, characterised in that component (I) is the compound:  2-[(a{[(a-methyl-3-trifluoromethyl-benzyl)imino]-oxy}-o-tolyl]-glyoxylic acid-methylester-O-methyloxime, and component (II) is a compound selected from the group: IIA) 5,7-dichloro-4-(4-fluorophenoxy)quinoline ("Quinoxyfen"); IIB) 4-cyclopropyl-6-methyl-N-phenyl-2-pyrimidinamine ("Cyprodinil"); IIC) benzo(1,2,3)thiadiazole-7-carbothio-acid-S-methylester ("Acibenzolar-S-methyl"); IID) 3-anilino-5-methyl-5-(4-phenoxyphenyl)-1,3-oxazolidine-2,4-dione ("Famoxadone"); IIE) 8-(1,1-dimethylethyl)-N-ethyl-N-propyl-1,4-dioxaspiro[4.5]decane-2-methanamine ("Sprioxamin"); IIF) 4-(2,2-difluoro-1,3-benzodioxol-4-yl)pyrrole-3-carbonitrile ("Fludioxonil"); IIG) 4-(2,3-dichlorophenyl)pyrrole-3-carbonitrile ("Fenpiclonil"); IIH) 1-methyl-cyclohexanecarboxylic acid-(2,3-dichloro-4-hydroxy-phenyl)-amide ("Fenhexamid"); IIJ) 2-{2-[6-(2-cyano-phenoxy)-pyrimidin-4-yloxy]-phenyl}-3-methoxy-acrylic acid methyl ester ("Azoxystrobin"); IIK) Methoximino-(2-o-tolyloxymethyl-phenyl)-acetic acid methyl ester ("Kresoxim-methyl"); or respectively one of the salts or metal complexes of components (I) and (II).
Patent NZ-504304-A (NZ)
Title: Information management and retrieval with means for identifying word sub-sets within word groups and outputting these
Inventor: WEEKS RICHARD
IPC: G06F17/30
Filed: 1998-11-18
Abstract: A method and apparatus is provided for extracting key terms from a data set, the method including the steps of identifying a first set of one or more word groups of one or more words that occur more than once in the data set, and removing from this first set a second set of word groups that are sub-strings of longer word groups in the first set. The remaining word groups are key terms. Each word group is weighted according to its frequency of occurrence within the data set. The weighting of any word group may be increased by the frequency of any sub-string of words occurring in the second set and then dividing each weighting by the number of words in the word group. This weighting process operates to determine the order of occurrence of the word groups. Prefixes and suffixes are also removed from each word in the data set. This produces a neutral form of each word so that the weighting values are prefix and suffix independent.
Patent NZ-509215-A (NZ)
Title: Transdermal plaster preparation containing at least one active ingredient which influences blood serum lipid levels
Inventor: BERTHOLD ACHIM
IPC: A61K45/00
Filed: 1999-07-07
Abstract: A preparation containing at least one active substance inhibiting hydroxymethylglutaryl-CoA reductase, which influences blood serum lipid levels of an organism, wherein the preparation is in the form of a transdermal therapeutic plaster containing the above active substance in a self-adhesive matrix layer which is located on the side opposite the skin and which can be covered by a backing layer that is impermeable to the active substance is disclosed.
Patent NZ-511572-A (NZ)
Title: Eudesmadienolide derivatives useful as glucose and lipid lowering compounds
Inventor: WAGLE DILIP
IPC: C07C69/78
Filed: 1999-11-10
Abstract: An eudesmadienolide derivative or pharmaceutically acceptable salts thereof has the formula (I) wherein: the dotted line between carbons 5 and 6, the dotted line between carbons 4 and R2, and the dotted line between carbon 11 and R3 each independently represent an optional double bond from the respective numbered carbon to a linked carbon; R1 is hydrogen, hydroxy, alkanoyloxy or optionally substituted aroyloxy; X is hydroxy or, together with Y is oxy linking carbon 8 and carbon 12; Y is hydroxy or an amino group that can be mono or di-substituted with alkyl, where the alkyls can be joined to form a five or six-membered ring; R2 and R3 are each independently alkyl or alkenyl group and the alkyl of R3 can be substituted with an amino group that can be mono or di-substituted with alkyl, where the alkyls can be joined to form a five or six-membered ring, with the provisos that:  (1) where X is hydroxy, then R1 is not hydrogen; (2) where R1 is hydrogen, then either a) X is hydroxy or b) R3 is substituted with amino, and (3) where R2 is methylene linked to C4 by a double bond, R3 is methylene linked to C11 by a double bond, and X is oxy, then R1 is not ethanoyloxy. The compounds are useful for lowering blood lipid levels or lowering blood glucose.
Patent NZ-512347-A (NZ)
Title: Bioassay for identifying estrogen receptor-alpha/beta selective modulators
Inventor: HARRIS HEATHER
IPC: C12Q1/6897
Filed: 1999-12-17
Abstract: A method of screening a test compound that binds to an Estrogen Receptor (ER) in a receptor binding assay by detecting ER-â polypeptide mediated transcription, comprising: a) providing a cell which has an estrogen-regulated DNA sequence encoding MT-II and a DNA sequence encoding ER-â polypeptide, wherein said receptor is transcriptionally active; b) contacting said cell with either the test compound which binds ER or a control; and c) detecting the expression of MT-II, wherein enhanced expression indicates the test compound has estrogen agonist activity, and reduced expression indicates the test compound has estrogen antagonist activity. Also covered is a variation of the above methodology, wherein a method is disclosed to screen test compounds to identify candidates that mimic estrogen's effect on ER-â or ER-á mediated transcription.
Patent NZ-514445-A (NZ)
Title: Bicyclic heteroaromatic compounds useful as LH agonists
Inventor: GERRITSMA GERRILDINA GEZIENA
IPC: C07D495/04
Filed: 2000-04-03
Abstract: A bicyclic heteroaromatic derivative or a pharmaceutically acceptable salt thereof are useful in fertility regulating therapies has the formula I wherein: R1 is NR5R6, OR5, SR5 or R7; R5 and R6 are independently H, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, alkylcarbonyl, arylcarbonyl, aryl or heteroaryl wherein the alkyl, alkenyl and alkynyl can be substituted or together form a heterocycloalkyl ring; R7 is cycloalkyl, heterocycloalkyl or optionally substituted aryl or heteroaryl; R2 is optionally substituted alkyl, alkenyl, alkynyl, aryl or heteroaryl,  X is S, O or NR4 ; R4 is H, alkyl, alkylcarbonyl, arylcarbonyl or arylalkyl; Y is CH or N; Z is NH2 or OH; A is S, NH, NR9, O or a bond; R9 can have the same meaning as for R2 and B is NH, O, or a bond.
Patent NZ-519681-A (NZ)
Title: Device for transferring powdery materials, and use for feeding a melting metal with powdery material
Inventor: ISSLER THOMAS
IPC: B22D27/20
Filed: 2001-10-29
Abstract: A device for transferring pulverulent material, for example, powdery material, including an enclosure (3) wherein the pulverulent material to be transferred is stirred and pressurized; a first pipe (8) and a second pipe (9) which transport the material towards its destination; and a gas intake (14, 15) for introducing gas to the second pipe (9).  Pipe (8) may form a nozzle (12), oriented in the direction of the material flow and directed toward second pipe (9).  The gas intake (14,15) may emerge at the lower end of the first pipe (8), outside the nozzle (12), wherein the gas is introduced into the second pipe (9) through a plurality of through orifices (20) oriented substantially parallel to the flow direction of the pulverulent material.
Patent NZ-521354-A (NZ)
Title: Non oxygen barrier packaging film and manufacture of the packaging film
Inventor: MEYER STEPHEN JOHN
IPC: B32B27/30
Filed: 2001-03-19
Abstract: A non-oxygen barrier packaging film is disclosed, which includes: (a) an outer layer comprising an ionomer to provide thermal resistance; and (b) an inner layer comprising a polymeric material having a sealing temperature lower than the sealing temperature of the outer layer, wherein the outer layer has a thickness of between 30-60% of the thickness of the packaging film. Also disclosed is a method of making a packaging film as described above, which includes the steps of (a) co-extruding a first layer comprising an ionomer and a second layer comprising a polymeric material having a sealing temperature lower than the first layer; and (b) cooling the co-extruded film. Further a method of packaging a food product is also described.
Patent NZ-522524-A (NZ)
Title: Micellar pharmaceutical compositions for buccal and pulmonary application
Inventor: MODI PANKAJ
IPC: A61K47/14
Filed: 2001-05-07
Abstract: Pharmaceutical compositions comprising a macromolecular pharmaceutical agent in mixed micellar form are disclosed. The mixed micelles are formed from an alkali metal alkyl sulfate, and at least three different micelle-forming compounds as described in the specification. Micelle size ranges between about 1 and 10 nanometers. Methods for making and using the compositions are also disclosed. A preferred method for administering the present composition is through the buccal region of the mouth.
Patent NZ-525734-A (NZ)
Title: Volume maintaining osteoinductive/oesteoconductive compositions
Inventor: SCARBOROUGH NELSON L
IPC: A61F2/28
Filed: 2000-10-13
Abstract: An osteoinductive/osteoconductive composition comprises (a) a quantity of demineralized fibrous bone elements possessing an average surface area to volume ratio of about 100: 1 to about 20:1 (b) a quantity of shaped non-fibrous bone elements possessing an average surface area to volume ratio of about 10:1 or less and (c) a sufficient quantity of biocompatible fluid carrier sufficient to provide the composition as a deformable mass. The composition is useful for packing into a bone defect site.
Patent NZ-529322-A (NZ)
Title: Use of zinc derivatives as cyclic ester polymerisation catalysts
Inventor: DUMITRESCU ANCA
IPC: C08G63/83
Filed: 2002-04-09
Abstract: Use of zinc derivatives of formula (I) as catalysts for polymerisation or co-polymerisation of cyclic esters is disclosed, wherein: L1 is selected from a group of formula: -E14(R14)(R'14)(R''14), -E15(R15)(R'15) and -E16(R16); E is an atom of group 15; L2 and L3 are independently selected from a group of formula: -E14(R14)(R'14)(R''14), -E15(R15)(R'15) and -E16(R16), or L2 and L3 combined form a chain of formula -L'2-A-L'3-; A is a saturated or unsaturated chain including 1 to 3 members independently selected from group 14 elements, each member being independently substituted by zero or one radical selected from an alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, aryl and substituted aryl, wherein the substituents in the substituted species being selected from a halogen, alkyl, aryl, nitro and cyano radical; L'2 and L'3 are independently selected from a group of formula -E14(R14)(R'14)-, -E15(R15) and -E16-; E14 is an element of group 14; E15 is an element of group 15; E16 is an element of group 16; R14, R'14, R''14, R15, R'15 and R16 are independently selected from a hydrogen, alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, aryl and substituted aryl, wherein the substituents in the substituted species being selected a halogen, alkyl, cycloalkyl, aryl, nitro, cyano radical and a radical of formula -EÆ14RRÆR"; EÆ14 is an element of group 14; and R, RÆ and R" are independently selected from a hydrogen, alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, aryl and substituted aryl, where in the substituted species one or more substituents are independently selected from a halogen, alkyl, aryl, nitro and cyano radical.
Patent NZ-531143-A (NZ)
Title: Bobbin for automatic inflator
Inventor: MACKAL GLENN H
IPC: B63C9/18
Filed: 2002-09-04
Abstract: A pill for insertion into a bobbin of a bobbin assembly of an automatic inflator, the pill including a distal surface and a proximal surface, at least one of the surfaces including an undulating configuration.
Patent NZ-538599-A (NZ)
Title: A method for the high level expression of active lymphotoxin-beta receptor immunoglobulin chimeric proteins and their purification
Inventor: BROWNING JEFFREY
IPC: C07K19/00
Filed: 1999-12-16
Abstract: A pharmaceutical preparation comprising a biologically active receptor Ig fusion protein comprising an Ig Fc domain and a member of the TNF family of receptors, wherein at least one cysteine residue in the hinge of the Fc domain is mutated to reduce the rate of disulfide formation and is replaced with an alanine residue. Also disclosed is a method for the high level expression of a biologically active receptor-Ig fusion protein.
Patent NZ-539839-A (NZ)
Title: Time-of-transaction foreign currency conversion
Inventor: BECK PHILIP D
IPC: G06Q20/00
Filed: 2003-11-07
Abstract: A method of performing a time-of-transaction currency conversion from a merchant's local currency to a card-holder's credit card currency is disclosed. The method includes the steps of receiving a request to authorise a transaction in a first currency, converting the request into a second currency, transmitting the request and amount in a second currency to an issuing bank, receiving a response approving the transaction and printing a transaction slip including the converted amount and a signature block for the cardholder to sign if they wish to decline having the transaction processed for the converted amount.
Patent NZ-540406-A (NZ)
Title: Method for improving the functional properties of a globular protein, protein thus prepared, use thereof and products containing the protein
Inventor: VEERMAN CECILE
IPC: A23L29/281
Filed: 2003-11-28
Abstract: Disclosed is a method for improving the functional properties of globular proteins, comprising the steps of: a) providing a solution of one or more globular proteins, in which the solution is at least partially aggregated in fibrils; and b) performing one or more of the following steps in random order: i. adjusting the pH of the solution to be about neutral; ii. increasing the salt concentration in the solution; iii. concentrating the solution; iv. changing the solvent quality of the solution.
Patent NZ-542525-A (NZ)
Inventor: WYETH MARTIN
IPC: A63B57/00
Filed: 2004-03-29
Abstract: A ball feeder for an automatic golf ball teeing system includes a tray 10 with a base 11 and opposing side walls 12, 13, the base having a ball inlet end 14 and a ball outlet end 15 and defining a ramp extending downwards from the inlet end to the outlet end. A scoop 17 receives a single transverse row of balls at the outlet of the tray and a mechanism 23, 26 is provided for raising the scoop into an elevated position to release the balls one at a time onto the tee 19 each time a ball is hit from the tee. The scoop 17, when elevated defines a second ramp that extends transversely to the ramp defined by the base of the tray. The side walls of the tray diverge from the inlet end to the outlet end so that balls do not become wedged in the tray.
Patent NZ-543180-A (NZ)
Title: Intervertebral implant
Inventor: GUTLIN MICHAEL
IPC: A61F2/30
Filed: 2003-04-28
Abstract: Intervertebral implant with A) a lower implant section 2, that has a hollow cylindrical cavity with a jacket and a rotation axis and an apposition section intended for placement on the top surface of the neighbouring lower vertebra, B) an upper implant section 5 with a shaft of generally circular-cylindrical design with external thread 7 and rotation axis, reaching into the cavity of the lower implant section 2 and an apposition section intended for placement on the top surface of the neighbouring upper vertebra, wherein C) the two implant sections 2 5 are secured against rotation around their rotation axis, and D) a ring 9 with internal thread 10 positioned between the two implant sections 2 5 which interacts with the external thread 7 of the upper implant section 5, wherein E) the two implant sections 2 5 and the ring 9 are arranged coaxial along their common rotation axis, so that F) by twisting of the ring 9 on the external thread 7 of the shaft the distance between the two apposition sections can be adjusted continuously, wherein G) the ring 9 is connected to the lower implant section 2 fixed in an axial but moveable in a rotational direction, and H) the ring 9 is provided with a lower circular ring surface facing the lower implant section 2 and an upper circular ring surface facing the upper implant section 5, wherein I) the lower circular ring surface is provided with a crown gear which is suitable for receiving a corresponding pinion, and J) the external thread 7 of the circular-cylindrical shaft and the internal thread 10 of the ring 9 have a self-locking feature.
Patent NZ-546488-A (NZ)
Title: Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and/or diabetes
Inventor: MINTZ LIAT
IPC: C12Q1/68
Filed: 2004-09-09
Abstract: Disclosed is an isolated nucleic acid molecule having the sequence as set forth in SEQ ID NO: 11 and a compliment thereof, or a nucleic acid fragment consisting of at least 17 base pairs corresponding to the coding region of the nucleic acid molecule, for the use in therapy. Also disclosed are proteins coded by this nucleic acid. In particular these compounds are to be used in the manufacture of a medicament for the treatment of obesity and/or diabetes.
Patent NZ-546775-A (NZ)
Title: Bioartificial implant and its use and method of reducing the risk for formation of connective tissue after implantation
Inventor: BRUCE ADAM
IPC: A61L27/50
Filed: 2004-10-04
Abstract: Provided is a bioartificial implant comprising a semipermeable barrier designed, from one side to allow diffusion or prevent diffusion of predetermined substances / materials / molecules / cells / cell lines to the other opposite side of the barrier; and from said other opposite side to allow diffusion or prevent diffusion of predetermined substances which are the same as or different from the first mentioned substances / materials / molecules / cells / cell lines, wherein said semipermeable barrier has a surface coating of a bioactive metal, said surface coating being permeable to allow or prevent said diffusions. Further provided are implants made of titanium, zirconium, tantalum or an alloy thereof, an insulin pump comprising such an implant and a method of reducing the risk of formation or growth of connective tissue adjacent to the implant.
Patent NZ-550250-A (NZ)
Title: Recombinantly modifed plasminogen
Inventor: HUNT JENNIFER AUDREY
IPC: C12N9/68
Filed: 2005-04-21
Abstract: Polynucleotides and polypeptides relating to a recombinantly-modified human plasminogen molecule are provided. The plasminogen molecule has a single kringle domain N-terminal to the activation site present in the native human plasminogen molecule, and exhibits lysine-binding and significant enzymatic characteristics associated with the native enzyme.
Patent NZ-554084-A (NZ)
Title: Device and method for detecting antibiotic-inactivation enzymes
Inventor: BLACK JENNIFER A
IPC: C12Q1/18
Filed: 2005-09-15
Abstract: A method for determining whether a microorganism produces an AmpC beta-lactamase is disclosed in which a culture of a microorganism suspected of producing a beta--lactamase that inactivates a beta-lactam-containing antibiotic is admixed with an effective amount of each of i) a beta-lactam-containing antibiotic, ii) a beta-lactamase inhibitor to which AmpC â--lactamase is resistant, and iii) a permeabilizing agent for the microorganism present in a non--growth-inhibiting microorganism-permeabilizing amount to form an assay culture. That assay culture is maintained under appropriate culture conditions and for a time period sufficient to determine the interaction of the microorganism with the AmpC beta-lactamase resistant inhibitor and antibacterial compound, and thereby determine the presence of an AmpC beta-lactamase, wherein a positive test indicates the presence of an AmpC beta-lactamase.
Patent NZ-560926-A (NZ)
Title: Multi part twist type closure assembly for a complementary container
Inventor: LINDSAY BRENDAN JON
Filed: 2005-03-04
Abstract: A dispensing closure assembly suitable to be engaged to a complementary container, the assembly comprising or including a first moulded component ("first component") 46 adapted to engage an outlet of a complementary container and having a column providing an outlet from which any liquid content of such a container can egress, the first component including a closure portion above the outlet and at least one formation at least partially circumferentially disposed from the column, adapted to guide and receive a complementary axial guide; a second moulded component ("second component") about the column of the first component and having a dispensing outlet capable of being closed by the closure portion of the first component, at least one axial guide of the second component co-acting with the formation of the first component, to restrict movement of the second component relative to the first component at least substantially to non-rotational axial movement; and a third moulded component ("third component") held captive by the first component but rotatable relative thereto, and being threadedly associated with the second component so that rotation of the third component can cause non-rotational axial movement of the second component relative to the first component to effect opening and closing of the dispensing outlet.